Innovative 3D Printing 'Glue Gun' Enables On-Site Bone Graft Fabrication During Surgery

A new 3D printing 'glue gun' allows surgeons to create personalized bone grafts directly onto fractures in real time, enhancing surgical precision, reducing operation time, and providing infection control. This innovative technology shows promise for transforming bone repair procedures.
Scientists have introduced a groundbreaking surgical tool inspired by a modified glue gun that utilizes 3D printing technology to create bone grafts directly onto fractures and defects during operation. This novel device, detailed in the journal Device, has undergone testing in animal models, specifically rabbits, demonstrating rapid, accurate formation of complex bone implants without pre-fabrication. The filament used in the device combines hydroxyapatite (HA), a natural component that facilitates healing, with polycaprolactone (PCL), a biocompatible thermoplastic, allowing for customizable properties.
The heated glue gun operates at temperatures low enough (around 60°C) to prevent tissue damage while conforming precisely to irregular bone surfaces. Surgeons can modify the printing direction, angle, and depth in real time, enhancing surgical precision and reducing operative time to mere minutes. This technique also incorporates antibacterial agents, vancomycin and gentamicin, embedded within the filament for localized infection control, releasing gradually over several weeks to prevent postoperative infections.
In animal studies, the scaffold supported effective bone regeneration, showing no infection or necrosis after 12 weeks, and surpassed traditional bone cement in key structural parameters. The biodegradable scaffold gradually degrades as new bone tissue forms, offering a promising solution for complex or irregular fractures without the need for preoperative imaging or custom implant design. This innovation paves the way for immediate, precise, and infection-resistant bone repair in surgical settings, with ongoing efforts aimed at clinical trials and regulatory approval.
Source: Medical Xpress
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Reinstatement of Hundreds of Laid-Off CDC Employees Marks a Shift in Public Health Workforce
Over 460 CDC employees who were laid off earlier this year are now being reinstated, signaling a shift in federal public health staffing. Learn more about the ongoing impact on CDC programs and operations.
Monitoring Antibiotic Resistance Spread Through Wastewater Surveillance at Mass Events
Wastewater surveillance reveals how mass gatherings accelerate the spread of antibiotic resistance genes, highlighting environmental risks and the importance of genomic monitoring in public health.
Distinct FOXA1 Mutations Drive Prostate Cancer Initiation and Therapy Resistance
New research reveals how two distinct FOXA1 gene mutation classes promote prostate cancer initiation and resistance to hormonal therapy, offering new therapeutic avenues.
Texas Allocates $50 Million for Psychedelic Drug Research to Combat Addiction
Texas commits $50 million to research ibogaine, a promising psychedelic for addiction and brain injury treatment, supporting clinical trials and innovation in neurotherapy.



